Insider filing · MDGL
Mardi Dier
SVP and CFO
profile →
Madrigal Pharmaceuticals, Inc.
MDGL · Healthcare · 59 filings in 24 months
ticker →
Mardi Dier sold $505K of Madrigal Pharmaceuticals (MDGL)
Executed Mar 2, disclosed Mar 2, the same day.
Value, as filed
$505K
1,183 sh × $427.21
Executed
Mar 2
the trade date, as filed
Disclosed
Mar 2
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MDMardi Dier (SVP and CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Madrigal Pharmaceuticals, Inc. (MDGL). The largest single filing was $2.1M of MDGL (3,579 sh across 10 lots, as filed), executed Dec 2 2025.
The name
MDGLHealthcare · Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Mardi Dier in MDGL
MDGLSALE
Madrigal Pharmaceuticals, Inc.
$458K1,066 sh across 2 lots
Exec Mar 6
Filed Mar 6 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $2.1M
3,579 sh across 10 lots
Exec Dec 2 2025
Filed Dec 3 2025 · 5:30 PM ET MDGLSALE Madrigal Pharmaceuticals, Inc. $637K
1,961 sh across 2 lots
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET